Papers
1
Total Citations
20
H-Index
1
About
David Lu is a prominent researcher in urologic oncology, with a specialized focus on the intersection of advanced imaging and prostate cancer outcomes. His work centers on leveraging multiparametric 3 Tesla magnetic resonance imaging (MRI) to improve the prediction of biochemical recurrence following robotic-assisted radical prostatectomy. In his highly cited 2017 study, Lu demonstrated how integrating pathological findings with volumetric MRI data—correlated against whole-mount histopathology—can identify key predictors of disease relapse. This contribution has been instrumental in refining post-surgical risk stratification, helping clinicians move beyond traditional clinical variables to incorporate imaging biomarkers for more personalized patient management. With over 20 citations on this pivotal paper alone, Lu’s research has shaped contemporary approaches to prostate cancer surveillance and treatment planning. His work underscores the growing role of quantitative MRI in urologic oncology, bridging radiology and pathology to enhance prognostic accuracy. For students and researchers, Lu exemplifies how translational imaging research can directly impact clinical decision-making in cancer care.
Research Focus
Key Achievements
Top Papers
- 1